Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Fetal and trophoblast PI3K p110α have distinct roles in regulating resource supply to the growing fetus

ABSTRACT: Fetal and trophoblast PI3K p110α have distinct roles in regulating resource supply to the growing fetus

PROVIDER: PRJNA520850 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR8526740.fastq.gz	Fastqsanger.gz
	SRR8526741.fastq.gz	Fastqsanger.gz
	SRR8526733.fastq.gz	Fastqsanger.gz
	SRR8526734.fastq.gz	Fastqsanger.gz
	SRR8526735.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 9

Similar Datasets

Fetal and trophoblast PI3K p110α have distinct roles in regulating resource supply to the growing fetus

Project description:Using RNA-seq we identified several genes downstream of p110α in the trophoblast that are important in adapting placental phenotype to support fetal growth.

2019-07-25 | GSE126046 | GEO

Fetal and trophoblast PI3K p110α have distinct roles in regulating resource supply to the growing fetus in mice.

Project description: Not available

| S-EPMC6634971 | biostudies-literature

LFQ of Campylobacter fetus subsp. fetus strains

Project description:Comparsion of proteomes of Campylobacter fetus subsp. fetus to compare protein level via iBAQ analysis, expression (by LFQ) and coverage between Campylobacter fetus subsp. fetus strain82-40 vs Campylobacter fetus subsp. fetus strain ATCC 27374

2020-05-25 | PXD014538 | Pride

Conditional loss of ErbB3 delays mammary gland hyperplasias induced by mutant PIK3CA but does not affect mammary tumor latency, gene expression or signaling

Project description:Mutations in PIK3CA, the gene encoding the p110α subunit of PI3K, induce transformation of mammary epithelial cells (MEC). Studies suggest the transforming action of mutant PIK3CA requires binding to activated receptor tyrosine kinases or adaptors. We examined in transgenic mice if ErbB3, a powerful activator of PI3K, is required for mutant PIK3CA-mediated MEC transformation. ErbB3 loss delayed PIK3CAH1047R-dependent mammary gland hyperplasia, but tumor latency, gene expression and markers of PI3K signaling were unaffected. In ErbB3-deficient tumors, mutant PI3K remained associated with other tyrosine phosphorylated adaptors, potentially explaining the dispensability of ErbB3 for tumorigenicity and PI3K activity. Combined inhibition of ErbB RTKs and PI3K with lapatinib and the p110α inhibitor BYL719, respectively, reduced PIK3CAH1047R-dependent tumor growth and PI3K signaling more potently than the p110α inhibitor alone. In human breast cancer cells harboring PIK3CAH1047R, the combination with BYL719 and an ErbB3 inhibitor synergistically inhibited tumor growth and P-Akt. These data suggest that basal tumor growth and PI3K signaling do not depend on ErbB RTKs in PIK3CAH1047R-expressing tumors. However, upon inhibition of p110α, these receptors limit the action of PI3K inhibitors potentially explaining the more potent effect of the combination against PI3K-mutant cancers. reference x sample

2013-06-20 | E-GEOD-43037 | biostudies-arrayexpress

Campylobacter fetus subsp. fetus 04/554

Project description:Campylobacter fetus subsp. fetus 04/554 Genome sequencing

| PRJNA177180 | ENA

Campylobacter fetus subsp. fetus strain:CITCf01

Project description:Campylobacter fetus subsp. fetus strain:CITCf01 Genome sequencing

| PRJNA716560 | ENA

Campylobacter fetus subsp. fetus strain:CITCf02

Project description:Campylobacter fetus subsp. fetus strain:CITCf02 Genome sequencing

| PRJNA716563 | ENA

Combined use of FoxM1 inhibitor, thiostrepton and the PI3K/mTOR dual inhibitor, GSK458, synergistically promotes an anticancer effect in ovarian clear cell carcinoma

Project description:Activating mutations in PIK3CA encoding p110α, the catalytic subunit of PI3K, have been described to occur in 33%–40% of OCCC. To testify whether Thiostrepton and GSK458 could exert synergistic anti-tumor effects against OCCC, we use RNA sequence from TOV21G cell line therapy groups.

2025-09-26 | GSE294871 | GEO

Campylobacter fetus subsp. fetus strain:HC1

Project description:Campylobacter fetus subsp. fetus strain:HC1 Genome sequencing and assembly

| PRJNA474633 | ENA

Campylobacter fetus subsp. fetus strain:493

Project description:Campylobacter fetus subsp. fetus strain:493 Genome sequencing and assembly

| PRJNA607418 | ENA